Neurogene NGNE
NASDAQ NGNE
$23.55 -0.73 (-3.01%)
At close: Oct 23, 2026 · 4:00 PM EDT

Neurogene (NGNE) Gains from Investment Securities (2013 - 2016)

Updated

Analysis

Neurogene (NGNE) Gains from Investment Securities (2013 - 2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Neurogene 531.10 Mn -471.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2016 8,000.00
Jun 30, 2016 23,000.00
Mar 31, 2016 50,000.00
Dec 31, 2015 18,000.00
Sep 30, 2015 -76,000.00
Jun 30, 2015 13,000.00
Mar 31, 2015 -7,000.00
Dec 31, 2014 -9,000.00
Sep 30, 2014 29,000.00
Jun 30, 2014 14,000.00
Mar 31, 2014 914,000.00
Dec 31, 2013 -10,757.00
Sep 30, 2013 24,871.00
Jun 30, 2013 947,886.00
API Access

Neurogene Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=NGNE&period=max&api_key=YOUR_API_KEY